Millennials: Should You Just Say No to Weed Stocks?

Millennials are advised to avoid weed stocks. CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST), Canopy Growth Corp (TSX:WEED)(NYSE:CGC), and the rest of the cannabis companies are dealing with issues that are affecting the industry as a whole.

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Weed stocks offer terrific growth potentials, yet millennials should think doubly hard before taking a position in Canada’s cannabis producers. If you’re inexperienced in the cannabis space, all the more reason to say no to weed stocks.

Aside from the lack of fundamentals (and profits), cannabis companies are giving the industry a bad image because of controversies and scandals. Canopy Growth (TSX:WEED)(NYSE:CGC) and CannTrust (TSX:TRST)(NYSE:CTST) are popular weed stocks. However, you shouldn’t risk your money on them.

Dangerous weed stock

CannTrust is not a trustworthy cannabis company. The company’s former chairman and CEO deliberately broke legal cannabis cultivation laws. CannTrust was cultivating cannabis from unlicensed cultivation rooms for six months and selling them to unsuspecting clients.

When Health Canada found out the anomaly through a random audit, CannTrust had no choice but to admit to the fraudulent operations. The expulsion and resignation of the CEO and chairman followed. The stock was trading as high as $10 in late April but has sunk to $2.20, or by 78%, as of this writing.

On August 1, 2019, the Ontario Securities Commission received an application from CannTrust for a management cease trade order. The investing public is free to trade the stock, but management, directors, and other insiders are prohibited.

The latest from the grapevine is that before the end of September, CannTrust will no longer be on the S&P/TSX Index. The company has lost its moral ascendancy. No one would dare to invest a weed stock that nearly brought the entire cannabis industry down.

The industry giant is high risk

The standing of Canopy Growth is not as grave as that of CannTrust. The largest cannabis company has no record of violating of cannabis regulations. However, the Canopy’s market value is down from $14 billion to $11 billion. The stock price was doing almost $70 in late April but is down by 55.53% to $33.23 today.

Canopy is posting losses at a torrid pace. The company’s founder and former CEO Bruce Linton was fired by the major partner and investor Constellation Brands. The American alcohol beverage giant did not like the excessive spending and mounting losses. Canopy lost more than $1 billion in the most recent quarter.

Unlike CannTrust, Canopy’s future is not bleak. In the next 12 months, analysts see the company’s revenue to increase by 290.9%. Its EBITDA in the same forecast, however, would be negative.

Despite being the cannabis industry’s giant, Canopy is not a profitable company. It would take a long time before business fundamentals improve. But Canopy will certainly achieve long-term sustainable growth.

“No buy” zone

Except for CannTrust, which is in dire straits, most of the weed stocks are in the same boat with Canopy Growth. Profits are as elusive as ever. There’s no way to tell when the industry will stabilize. At present, volatility is at an all-time high.

As mentioned earlier, the weak fundamentals, controversies, and scandals are sufficient reasons to declare the cannabis sector a “no buy” zone. Millennials, as well as baby boomers, should be smart enough to look for less-risky stocks that offer sure returns.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »